Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
11
2022
Behavioral Health Law Ledger | March 2022 Greenberg Traurig, LLP
Mar
11
2022
U.S. Department of Agriculture Proposes Rule Requiring Contractors to Certify Labor Law Compliance Proskauer Rose LLP
Mar
11
2022
Sugar Association Files Supplemental Petition Urging Regulatory Changes for Artificially Sweetened Foods Keller and Heckman LLP
Mar
11
2022
FDA Publishes Proposed Rule on National Standards for The Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers as Required by The Drug Supply Chain Security Act
Mar
10
2022
California’s ‘FAST Recovery Act’: The Anticipated Impact on the Restaurant Industry, Franchise Industry, Jobs, and Food Prices Greenberg Traurig, LLP
Mar
10
2022
EUON Launches Two Calls for Tenders to Conduct Studies on Nanomaterials Bergeson & Campbell, P.C.
Mar
10
2022
Permanent Injunction against Supplement Co. Keller and Heckman LLP
Mar
10
2022
UK Calorie Labelling for Food and Drink in Restaurants, Takeaways, Deli Counters and Other ‘Out of Home’ Squire Patton Boggs (US) LLP
Mar
9
2022
EPA Releases Response Denying Objections to Its Final Rule Revoking All Tolerances for Chlorpyrifos Bergeson & Campbell, P.C.
Mar
9
2022
January 2022 State Regulatory Developments Giordano, Halleran & Ciesla, P.C.
Mar
9
2022
NY Judge Denies Dismissal of Free-Range Egg Suit Keller and Heckman LLP
Mar
9
2022
Takeaways from the 2022 Industrial Hemp Summit Ward and Smith, P.A.
Mar
8
2022
EPA Further Postpones TSCA Compliance Date for Articles Containing PIP Keller and Heckman LLP
Mar
8
2022
EPA Publishes Final Scope of D4 Risk Evaluation, Seeks Comment on Draft Revision to PV29 Risk Determination Bergeson & Campbell, P.C.
Mar
8
2022
FDA Announces Enforcement Discretion for Genome-Edited Beef Cattle Keller and Heckman LLP
Mar
8
2022
FDA Issues Final Guidance for Initiation of Voluntary Recalls McDermott Will & Emery
Mar
8
2022
Manufacturers Must Consider Employee Use of Prescription Medications on an Individualized Basis Jackson Lewis P.C.
Mar
7
2022
Focus on Food Safety: How Proposed Amendments to the Agricultural Water Rule Will Impact Farmers Womble Bond Dickinson (US) LLP
Mar
7
2022
FDA Releases Final Guidance and Urges Companies to be ‘Recall Ready’ Keller and Heckman LLP
Mar
4
2022
Big Beer Says Prices have Remained Low While Craft Brewers Welcome the Scrutiny. MoginRubin
Mar
4
2022
The Fun and Whimsical (but Crowded) Landscape of Beer Names Part 2 Ward and Smith, P.A.
Mar
3
2022
Second Butter Cracker Case Dismissed Keller and Heckman LLP
Mar
2
2022
Initiating Action With Only Brain Power Womble Bond Dickinson (US) LLP
Mar
2
2022
Similac Baby Formula Recall & Enfamil and Similac Formula Lawsuits Buckfire Law
Mar
2
2022
Lawsuit Filed Over Misleadingly Labeled “Brown Bread” Keller and Heckman LLP
Mar
1
2022
FDA Issues Proposed Rule to Amend Medical Device Quality System Regulation McDermott Will & Emery
Mar
1
2022
Unpacking Averages: Connecting Published Clinical Trials with FDA Drug Approvals Epstein Becker & Green, P.C.
Mar
1
2022
Massachusetts COVID-19 Emergency Paid Sick Leave Act to End on March 15, 2022 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins